Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial
Status:
Not yet recruiting
Trial end date:
2024-10-31
Target enrollment:
Participant gender:
Summary
The pathophysiological implications of various cancer diseases and anti-cancer therapies is
the occurrence of a cardiac disease-like phenotype with cardiac dysfunction, cardiac wasting,
and cardiac homeostasis changes (incl. fibrosis and apoptosis) in end-stage cancer patients,
causing heart failure like syndrome with development of congestion, dyspnoea and severely
reduced physical functioning. The present trial aims to evaluate, if a heart failure
medication improves the self-care ability and self-reported health care status of patients
with pre-terminal cancer in palliative care.